We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$2.35B
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 17.11% |
| 3 | Miscellaneous | 15.83% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Financials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Repligen
RGEN
$9.51B
| $63.6M | 0.12% |
449,488
+263,259
| +141% | +$42.2M |
|
177
Palantir
PLTR
$409B
| $63.3M | 0.12% |
+4,128,495
| New | +$46.9M |
|
178
Vertex Pharmaceuticals
VRTX
$134B
| $63.3M | 0.12% |
179,800
-213,329
| -54% | -$71.9M |
|
179
monday.com
MNDY
$3.54B
| $62.5M | 0.12% |
365,229
-142,425
| -28% | -$21.3M |
|
180
Weatherford International
WFRD
$6.7B
| $61.9M | 0.12% |
931,750
+428,326
| +85% | +$26.4M |
|
|
BKI
181
DELISTED
Black Knight, Inc. Common Stock
BKI
| $61.8M | 0.12% |
1,034,041
-208,660
| -17% | -$11.7M |
|
182
Albertsons Companies
ACI
$5.89B
| $61.4M | 0.12% |
2,814,624
-4,100,874
| -59% | -$85.3M |
|
183
Grocery Outlet
GO
$1.16B
| $61.2M | 0.12% |
1,998,001
-520,118
| -21% | -$15.2M |
|
184
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.1B
| $60.8M | 0.12% |
715,600
+667,000
| +1,372% | +$51.1M |
|
185
Option Care Health
OPCH
$3.56B
| $59.9M | 0.12% |
1,844,319
+194,195
| +12% | +$5.85M |
|
|
SWN
186
DELISTED
Southwestern Energy Company
SWN
| $59.5M | 0.12% |
9,907,553
+2,448,511
| +33% | +$12.6M |
|
|
187
CALL
Apple
AAPL
$4.61T
| $59.3M | 0.12% |
305,900
-328,800
| -52% | -$57.3M |
|
188
Datadog
DDOG
$75.5B
| $59.1M | 0.12% |
601,082
+245,175
| +69% | +$20.5M |
|
189
Realty Income
O
$57.7B
| $58.6M | 0.11% |
980,038
+221,169
| +29% | +$13.5M |
|
190
L3Harris
LHX
$47.6B
| $57.9M | 0.11% |
295,919
-10,710
| -3% | -$2.05M |
|
191
Vulcan Materials
VMC
$33.5B
| $57.6M | 0.11% |
255,321
-137,131
| -35% | -$26.3M |
|
192
Netflix
NFLX
$320B
| $56.7M | 0.11% |
1,286,340
-1,965,860
| -60% | -$72.4M |
|
193
Lamb Weston
LW
$6.79B
| $56.3M | 0.11% |
490,204
-683,526
| -58% | -$76.2M |
|
194
Ingersoll Rand
IR
$29.1B
| $56.3M | 0.11% |
860,686
+473,532
| +122% | +$28M |
|
195
Royalty Pharma
RPRX
$27B
| $55.5M | 0.11% |
1,806,621
+1,134,091
| +169% | +$38.4M |
|
196
iShares MSCI India ETF
INDA
$6.66B
| $55.4M | 0.11% |
1,268,622
-238,736
| -16% | -$9.89M |
|
197
Hims & Hers Health
HIMS
$6.57B
| $55.2M | 0.11% |
5,875,867
+1,904,930
| +48% | +$18.9M |
|
|
XIFR
198
XPLR Infrastructure LP
XIFR
$1.16B
| $55.1M | 0.11% |
939,918
-622,852
| -40% | -$37.5M |
|
199
PPG Industries
PPG
$24.4B
| $55.1M | 0.11% |
371,489
+348,735
| +1,533% | +$48.7M |
|
200
MasTec
MTZ
$19.8B
| $54.6M | 0.11% |
463,181
-56,618
| -11% | -$5.54M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $2.35B of net new capital in Q2 2023, opening 648 new positions and adding to 710 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was Gilead Sciences, an estimated $402M trimmed.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.